Charles A Sanders - Net Worth and Insider Trading
Charles A Sanders Net Worth
The estimated net worth of Charles A Sanders is at least $13 Million dollars as of 2024-11-13. Charles A Sanders is the Director of Vertex Pharmaceuticals Inc and owns about 26,383 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $13 Million. Charles A Sanders is also the Director of BioCryst Pharmaceuticals Inc and owns about 7,000 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $54,740. Details can be seen in Charles A Sanders's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Charles A Sanders has not made any transactions after 2012-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Charles A Sanders
Charles A Sanders Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Charles A Sanders owns 3 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) , Albireo Pharma Inc (ALBO) , and Vertex Pharmaceuticals Inc (VRTX) .
Click here to see the complete history of Charles A Sanders’s form 4 insider trades.
Insider Ownership Summary of Charles A Sanders
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2012-03-13 | director |
| ALBO | Albireo Pharma Inc | 2007-05-10 | director |
| VRTX | Vertex Pharmaceuticals Inc | 2009-05-18 | director |
Charles A Sanders Latest Holdings Summary
Charles A Sanders currently owns a total of 2 stocks. Among these stocks, Charles A Sanders owns 26,383 shares of Vertex Pharmaceuticals Inc (VRTX) as of May 18, 2009, with a value of $13 Million and a weighting of 99.58%. Charles A Sanders also owns 7,000 shares of BioCryst Pharmaceuticals Inc (BCRX) as of March 13, 2012, with a value of $54,740 and a weighting of 0.42%.
Latest Holdings of Charles A Sanders
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2009-05-18 | 26,383 | 490.00 | 12,927,670 |
| BCRX | BioCryst Pharmaceuticals Inc | 2012-03-13 | 7,000 | 7.82 | 54,740 |
Holding Weightings of Charles A Sanders
Charles A Sanders Form 4 Trading Tracker
According to the SEC Form 4 filings, Charles A Sanders has made a total of 0 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 3,333 shares on May 18, 2009, which brought Charles A Sanders around $94,791.
According to the SEC Form 4 filings, Charles A Sanders has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 2,000 shares on March 13, 2012, which cost Charles A Sanders around $10,440.
Insider Trading History of Charles A Sanders
- 1
Charles A Sanders Trading Performance
GuruFocus tracks the stock performance after each of Charles A Sanders's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Charles A Sanders is -7.93%. GuruFocus also compares Charles A Sanders's trading performance to market benchmark return within the same time period. The performance of stocks bought by Charles A Sanders within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Charles A Sanders's insider trading performs compared to the benchmark.
Performance of Charles A Sanders
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -8.42 | | | | | |
| Relative Return to S&P 500(%) | -9.8 | | | | | |
Charles A Sanders Ownership Network
Ownership Network List of Charles A Sanders
Ownership Network Relation of Charles A Sanders
Charles A Sanders Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Charles A Sanders is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Charles A Sanders made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Charles A Sanders Mailing Address
Above is the net worth, insider trading, and ownership report for Charles A Sanders. You might contact Charles A Sanders via mailing address: 100 Europa Drive Ste 170, Chapel Hill Nc 27514.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
